Charles expertise is in genetic engineering and, more specifically, the gene-editing and activity modifying system CRISPR-Cas9. There has been a wide assortment of stories in the press about this emerging technology recently. Cheaper, faster and more accurate than previous genetic editing techniques, CRISPR-Cas9 will help scientists better understand the root causes of genetic diseases and perhaps fix them.